Business Survival Value Multiplier

Standard valuation
has a missing variable.
We added it.

Every DCF model, every goodwill calculation, every real option analysis assumes the firm will survive. ~50% of firms don't. And the probability varies by sector — by a margin too large to ignore. BSVM is the sector-calibrated correction that brings valuation in line with what the data has always been saying.

Request a Review → How It Works
~50%
of firms exit before year 5
10.5 pp
survival spread across sectors
$765B
S&P 500 goodwill impairments 2008–2023
The Evolution
Valuation 2.0

Valuation 1.0 adjusts for cash flow variability — the risk that projected revenues don't materialize.
Valuation 2.0 also adjusts for survival probability — the risk that the firm doesn't exist to generate them.
One variable. Decades of data. Defensible in any jurisdiction.

What We Do

We don't replace your valuation.
We complete it.

You already have the model. You already have the projections. BSVM adds the one variable that standard practice has always been missing — and delivers a defensible, documented correction with a 95% confidence interval.

What You Receive
Five-part deliverable
Every BSVM Review returns the same five elements, regardless of asset type:
01 Diagnosis — what the original report assumes about survival and why it matters
02 Adjusted Value — sector-calibrated survival correction applied to the original valuation
03 VaR (absolute + %) — value at risk with 95% bootstrap CI
04 Calculation Trail — sector classification, multiplier, horizon, confidence bounds — fully traceable
05 Technical Opinion — signed, defensible in audit, arbitration, litigation
Example output — Goodwill review · Construction sector (NAICS 23)
Original goodwill (as stated in the report) $10,000,000
Sector: Construction · Sector survival profile applied Survival multiplier applied
BSVM-adjusted value (central estimate) $6,470,000
95% confidence interval $5,890,000 — $7,180,000
95% CI · 1,000,000+ iterations · compatible with Level 3 ASC 820 / IFRS 13
Value at Risk — absolute $4,110,000
Value at Risk — percentage of stated goodwill 41.1%
VaR interpretation: with 95% statistical confidence, $4.1M of the stated goodwill is exposed to impairment due to sector survival risk alone — before any firm-specific or market-cycle risk is considered.
Retroactive Validation

What BSVM would have flagged
before the impairment.

Applied retroactively to two of the largest goodwill impairment events in U.S. history. All figures from public SEC filings. BSVM did not exist at the time of these transactions — but the sector survival data did.

AOL Time Warner
Merger closed Jan 2001 · Information sector (NAICS 51)
Goodwill recorded at closing$127B
BSVM-adjusted value$87.1B
Day-1 impairment exposure reduction− $39.9B
Actual impairment recognized (2002)$99.8B
BSVM would have flagged a 31.5% overstatement on closing day — 12 months before the first impairment charge.
Kraft Heinz
Merger closed Jul 2015 · Manufacturing sector (NAICS 31–33)
Goodwill recorded at closing$31.6B
BSVM-adjusted value$21.9B
Day-1 impairment exposure reduction− $9.7B
Actual goodwill impairments 2018–2020$10.6B
The BSVM sector discount would have absorbed 91% of total goodwill impairments over the following five years.
FAQ

Questions we get asked
before the first engagement.

If something is still unclear after reading this, write to us — we respond within 24 hours.

The BSVM Review is a technical opinion on the going concern assumption embedded in an existing valuation — not a new valuation. We do not replace the original appraiser's work. We add the one variable that standard practice systematically omits: the probability that the firm being valued will survive to generate the projected cash flows.

You send us the report and the underlying model. We apply the sector-calibrated survival multiplier, calculate the Value at Risk with a 95% confidence interval, and return a signed technical document ready to attach to the original report or to submit independently in litigation, arbitration, or audit.

The WACC adjusts for cash flow variability given that the firm survives. It does not adjust for the probability that the firm does not survive at all. These are two fundamentally different risk dimensions.

Think of it this way: even if you project that the firm's revenues could be 20% lower than expected (cash flow variability, captured by WACC), the model still assumes the firm will be operating in years 3, 5, and 10 with certainty. The empirical data says approximately half of firms won't be. BSVM prices that second dimension. The two corrections are additive, not substitutes.

No — and this is one of the most common misconceptions. The retroactive case studies in this site are AOL Time Warner (2001) and Kraft Heinz (2015) — both large-cap public companies acquired in landmark transactions. The goodwill overstatement documented in both cases was structural and sector-level, not firm-specific.

The BSVM correction is relevant whenever a valuation assumes that the firm being acquired will generate cash flows over a multi-year horizon. That assumption is embedded in every M&A transaction regardless of firm size. The structural, sector-level survival risk captured by BSVM is separate from firm-specific risk — both are necessary, neither substitutes for the other.

Any asset valued by the income approach — where a projection of future cash flows is discounted to present value — can be reviewed with BSVM. This includes:

Goodwill (standard PPA horizon) · Brands and trademarks (Royalty Relief, indefinite or finite useful life) · Patents and inventions (remaining legal protection, with technological obsolescence adjustment) · Real options (survival-adjusted underlying asset before option pricing) · Customer relationships (average retention period) · Technology assets (economic useful life).

Each asset type has a different valuation horizon, and the survival correction is recalibrated accordingly. A patent with 7 years of remaining protection carries a different survival profile than goodwill on a standard PPA horizon.

The sector multiplier is derived from a proprietary calibration of historical establishment survival data, covering multiple decades and a comprehensive set of industry sectors. The methodology is proprietary to BSVM™.

What matters for the engagement is what the multiplier delivers: a sector-appropriate correction to the going concern assumption, expressed as a central estimate and a 95% statistical confidence interval. The full calculation trail accompanies every BSVM Review — sector classification, multiplier applied, valuation horizon, and the statistical bounds — fully traceable and auditable.

Parameters are updated annually as new historical data becomes available.

Four elements make the BSVM opinion defensible in any professional context:

Data source: Historical establishment survival data from government statistical agencies — not proprietary estimates or model assumptions. The underlying data is institutional, longitudinal, and independent of any party to the transaction.

Method: A calibrated statistical model with documented methodology currently in the academic publication process. The approach follows standard econometric practice for survival analysis.

Quantification: The 95% statistical confidence interval converts the survival correction into a defensible range — not a subjective discount. Courts, auditors, and arbitrators can evaluate it against objective statistical criteria.

Documentation: Every review includes a complete calculation trail and a signed technical opinion. The methodology is referenced to a working paper, providing an independent academic anchor for the going concern correction.

Yes — and Level 3 is precisely where BSVM is most relevant. Intangible assets fall invariably into Level 3 of ASC 820 / IFRS 13 because they have no active secondary market for price comparison. The appraiser is forced to rely on unobservable inputs, which makes a deterministic valuation — a single fixed number — insufficient for current banking compliance standards.

The BSVM Review delivers what deterministic valuation cannot: a statistically grounded risk range — absolute VaR, percentage VaR, and a 95% confidence interval computed from more than 1,000,000 iterations. This metric translates Level 3 uncertainty into the risk language accepted by credit committees and aligned with Basel III and ASC 946 / IFRS 9 expected-loss requirements.

For valuations used in IP-backed finance or credit collateral assessments, presenting a VaR with a 95% CI is what distinguishes an accepted guarantee from a rejected one. The BSVM opinion provides that metric — documented, traceable, and defensible.

Minimum required to begin a review:

1. The original valuation report (PDF) · 2. The underlying financial model (Excel) with the DCF projection · 3. The primary NAICS sector code of the target company.

Turnaround: 3 to 5 business days after receipt of complete documentation. We will send you a specific intake questionnaire after the initial contact, tailored to the asset type being reviewed.

Calibration

Built on real data.
Continuously updated.

Calibrated from decades of historical establishment survival data across a comprehensive set of industry sectors. Sector coverage in continuous expansion. Parameters updated annually as new data becomes available.

Data foundation
Decades
of establishment survival data · comprehensive sector coverage · government statistical sources
Confidence interval
95% CI
1,000,000+ iterations · compatible with Level 3 ASC 820 / IFRS 13 · Basel III aligned
Annual update
Yes
parameters recalibrated as new cohort data becomes available · always current
Who Uses BSVM

For everyone who signs off
on a valuation and owns the result.

The BSVM Review doesn't replace existing workflows. It adds the going concern variable that every valuation already uses implicitly — and makes it explicit, quantified, and defensible.

⚖️
M&A Counsel & Law Firms
Document the going concern discount as a methodology-backed contractual term. Defensible in arbitration, regulatory review, and shareholder litigation. Converts a silent assumption into an explicit, sector-calibrated argument.
📋
Valuation Firms & Big 4
Add the survival variable to PPA engagements (ASC 805 / IFRS 3) before signing. Reduces auditor challenge risk on the going concern assumption in subsequent ASC 350 impairment testing. Peer-reviewed methodology, fully documented.
🏦
Private Equity & Family Offices
Pre-LOI triage: flag targets in high-mortality sectors before the goodwill negotiation. Calibrate earn-out windows to sector survival profiles. Engagement per deal or monthly retainer.
🔬
Innovation & Technology Licensing
For patent and invention valuations: the BSVM Review adds both the sector survival correction and a technological obsolescence factor. The VaR with 95% CI and 1,000,000+ iterations converts the Level 3 ASC 820 / IFRS 13 valuation into a statistically grounded range — accepted by credit committees and aligned with Basel III prudential requirements.
Get Started

Request a BSVM Review
or schedule a consultation.

BSVM Reviews are by engagement — 3 to 5 business days turnaround. We respond to all inquiries within 24 hours.

contact@bsvmvaluation.com · We respond within 24 hours.

✓ Request received — we'll be in touch within 24 hours.
contact@bsvmvaluation.com